Evidence map›Paper›PMID 36009505›Full record

ReviewBiomedicines2022

Metabolic Syndrome and Overactive Bladder Syndrome May Share Common Pathophysiologies.

Lin-Nei Hsu, Ju-Chuan Hu, Po-Yen Chen, Wei-Chia Lee, Yao-Chi Chuang

Open access · goldAbstract readReview
In one paragraph

Review in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
16.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Lin-Nei HsuDepartment of Urology, An Nan Hospital, China Medical University, Tainan City 833, Taiwan.
Ju-Chuan HuDivision of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung 407, Taiwan.ORCID 0000-0002-2521-4043
Po-Yen ChenDivision of Urology, Yunlin Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Yunlin 638, Taiwan.ORCID 0000-0002-7250-2478
Wei-Chia LeeDivision of Urology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 807, Taiwan.ORCID 0000-0003-0701-2285
Yao-Chi ChuangDivision of Urology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 807, Taiwan.ORCID 0000-0002-1468-3792
Chang Gung University · TWChina Medical University · TWTaichung Veterans General Hospital · TW

Funding

Kaohsiung Chang Gung Memorial Hospital CMRPG8J0271-3Kaohsiung Chang Gung Memorial Hospital CMRPG8J0431Kaohsiung Chang Gung Memorial Hospital CMRPG8K1431Kaohsiung Chang Gung Memorial Hospital CMRPG8M0741-43Ministry of Science and Technology MOST 108-2314-B-182A-033-MY3Ministry of Science and Technology MOST 111-2314-B-182A-081-MY3
6 · The paper itself

Abstract

Metabolic syndrome (MetS) is defined by a group of cardiovascular risk factors, including impaired glucose tolerance, central obesity, hypertension, and dyslipidemia. Overactive bladder (OAB) syndrome consists of symptoms such as urinary urgency, frequency, and nocturia with or without urge incontinence. The high prevalences of metabolic syndrome (MetS) and overactive bladder (OAB) worldwide affect quality of life and cause profound negative impacts on the social economy. Accumulated evidence suggests that MetS might contribute to the underlying mechanisms for developing OAB, and MetS-associated OAB could be a subtype of OAB. However, how could these two syndromes interact with each other? Based on results of animal studies and observations in epidemiological studies, we summarized the common pathophysiologies existing between MetS and OAB, including autonomic and peripheral neuropathies, chronic ischemia, proinflammatory status, dysregulation of nutrient-sensing pathways (e.g., insulin resistance at the bladder mucosa and excessive succinate intake), and the probable role of dysbiosis. Since the MetS-associated OAB is a subtype of OAB with distinctive pathophysiologies, the regular and non-specific medications, such as antimuscarinics, beta-3 agonist, and botulinum toxin injection, might lead to unsatisfying results. Understanding the pathophysiologies of MetS-associated OAB might benefit future studies exploring novel biomarkers for diagnosis and therapeutic targets on both MetS and OAB.

Indexed as

insulin resistancemetabolic syndromemicrobiotaneuropathyobesityoveractive bladderproinflammation

Identifiers

PMID36009505
PMCPMC9405560
OpenAlexW4291415366

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.